Affinity

Affinity (Shanghai) Biopharmaceutical Co., Ltd. engages in the research and development of biopharmaceutical technologies and products (excluding the development and application of human stem cell, gene diagnosis, and gene therapy technologies), transfers its proprietary technological achievements, and provides related technical consulting and services. The company is dedicated to the clinical development of global innovative drugs with tumor microenvironment-specific activation capabilities, as well as the research and development of its technology platforms and early-stage pipeline, to address the substantial unmet clinical needs in the field of oncology.